Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The Indian generic drugs company Cipla will spend about $20 million to build a biosimilars plant in Durban, South Africa. Scheduled to come on-line in 2018, the plant, which will mostly produce cancer drugs, will employ about 300 people. Cipla says it hopes that its investment will help make biologic drugs affordable for 20% of the country’s patients, up from just 2% currently.
This article has been sent to the following recipient: